Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-18

Clinical Trial Update: Study of Danirixin in Japanese Healthy Elderly Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 study of danirixin in Japanese healthy elderly male subjects completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Danirixin (danirixin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED | Results posted: 2019-04-18